The pharmaceutical industry is to push for the versatile use of incremental cost-effectiveness ratio (ICER).

Related industry sources reported, a third meeting for the public-private consultative council to improve the drug pricing would be held on Mar. 19. Director Yang Yoon Seok and Deputy Director Choi Kyung-Ho of Pharmaceutical Benefits Division at Ministry of Health and Welfare (MOHW), representatives from National Health Insurance Service (NHIS), Health Insurance Review and Assessment Service (HIRA), Korean Research-based Pharmaceutical Industry Association (KRPIA), Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) and Korea Biomedicine Industry Association (KoBIA) would parti